admin
Admin
posted on
Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the SEC late Friday.
Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the SEC late Friday.
Comments
0 comment